administration of Akkermansia muciniphila
metabolic disorders
obesity
efficacy of Akkermansia muciniphila administration
Akkermansia muciniphila-based products
higher abundance of Akkermansia muciniphila
beneficial effects of Akkermansia muciniphila administration
cardio-metabolic risk factors
increased cardio-metabolic risk
better cardio-metabolic status
treatment of overweight
interesting therapeutic solution
body weight gain
insulin resistance
diabetes
obese people
obese patients
type
obese mice
therapeutic potential
dyslipidemia
fat mass gain
gut microbiota
human study
calorie restriction diet
environmental factors able
influence host metabolism
putative interesting microbial candidate
cholesterolemia
glycemia
subjects
low-grade inflammation
inflammatory markers
hypertension
safety
ERC POC project
comorbidities
individual susceptibility
major public health problem
Microbes4U
main objective
humans
proof of concept
bacteria
epidemic level
observations
demonstration